Orchestra BioMed Holdings, Inc. Ordinary Shares
$5.84
Market Cap
$361.23M
Shares Outstanding
60.1M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jan 27, 2023
Round Lot
100
Locale
US
Day Open
$6.03
Day High
$6.26
Day Low
$5.79
Volume
285.1K
VWAP
$5.88
Prev Close
$6.01
Transactions
--
Acc. Volume
--
Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.
Orchestra BioMed Holdings, Inc. Ordinary Shares (OBIO) closed the 2026-09-17 session at $5.84, down 2.83% versus the previous close (-0.17). The stock opened at $6.03 and traded between $5.79 and $6.26 during that session. Session trading volume was 285K shares. The volume-weighted average price (VWAP) is $5.88.
Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.
Orchestra BioMed Holdings, Inc. Ordinary Shares has a market capitalization of $361.2 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. OBIO is listed on the XNAS exchange. The company employs approximately 86 people. Orchestra BioMed Holdings, Inc. Ordinary Shares is headquartered in NEW HOPE, PA. The recorded listing date is 2023-01-27.
On this page you can find market OBIO stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.